1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > Australia Clinical Chemistry Market Outlook to 2021

Australia Clinical Chemistry Market Outlook to 2021

  • October 2015
  • -
  • GlobalData
  • -
  • 37 pages

Australia Clinical Chemistry Market Outlook to 2021

Summary

GlobalData’s new report, "Australia Clinical Chemistry Market Outlook to 2021", provides key market data on the Australia Clinical Chemistry market. The report provides value, in millions of US dollars within market segments - Clinical Chemistry Analyzers, Clinical Chemistry Rapid Tests & POC, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, Metabolite Chemistry Reagents, Therapeutic Drug Monitoring and Urine Analysis.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Clinical Chemistry market includes Clinical Chemistry Analyzers, Clinical Chemistry Rapid Tests & POC, Enzyme Chemistry Reagents, Electrolyte Chemistry Reagents, Metabolite Chemistry Reagents, Therapeutic Drug Monitoring and Urine Analysis.
- Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Clinical Chemistry market.
- Global corporate-level profiles of key companies operating within the Australia Clinical Chemistry market.
- Key players covered include Abbott Laboratories, Siemens Healthcare, F. Hoffmann-La Roche Ltd., Danaher Corporation, Ortho-Clinical Diagnostics Inc., bioMerieux S.A. and Bio-Rad Laboratories, Inc.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table Of Contents

Australia Clinical Chemistry Market Outlook to 2021
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 3
2 Introduction 4
2.1 What Is This Report About? 4
2.2 Clinical Chemistry Market Segmentation 4
2.3 Definitions of Markets Covered in the Report 5
3 Clinical Chemistry Market, Australia 8
3.1 Clinical Chemistry Market, Australia, Revenue ($m), 2007-2014 8
3.2 Clinical Chemistry Market, Australia, Revenue ($m), 2014-2021 10
3.2.1 Clinical Chemistry Analyzers Market, Australia, Revenue ($m), by Segment, 2007-2014 12
3.2.2 Therapeutic Drug Monitoring Market, Australia, Revenue ($m), by Segment, 2007-2014 14
3.2.3 Urine Analysis Market, Australia, Revenue ($m), by Segment, 2007-2014 16
3.2.4 Clinical Chemistry Analyzers Market, Australia, Revenue ($m), by Segment, 2014-2021 18
3.2.5 Therapeutic Drug Monitoring Market, Australia, Revenue ($m), by Segment, 2014-2021 20
3.2.6 Urine Analysis Market, Australia, Revenue ($m), by Segment, 2014-2021 22
3.3 Clinical Chemistry Market, Australia, Distribution Share by Revenue ($m), 2013-2014 24
3.4 Clinical Chemistry Market, Australia, Company Share by Revenue ($m), 2014 25
4 Overview of Key Companies in Australia, Clinical Chemistry Market 27
4.1 Siemens Healthcare 27
4.1.1 Company Overview 27
4.2 F. Hoffmann-La Roche Ltd. 27
4.2.1 Company Overview 27
4.3 bioMerieux S.A. 27
4.3.1 Company Overview 27
4.4 Abbott Laboratories 28
4.4.1 Company Overview 28
4.5 Danaher Corporation 28
4.5.1 Company Overview 28
4.6 Bio-Rad Laboratories, Inc. 28
4.6.1 Company Overview 28
4.7 Sysmex Corporation 29
4.7.1 Company Overview 29
5 Clinical Chemistry Market Pipeline Products 30
6 Financial Deals Landscape 33
6.1 Partnerships 33
6.1.1 NoemaLife Enters into Distribution Agreement with Horiba Medical 33
7 Appendix 34
7.1 Research Methodology 35
7.1.1 Coverage 35
7.1.2 Secondary Research 35
7.1.3 Primary Research 35
7.1.4 Company Share Analysis 36
7.1.5 Distribution Share Analysis 36
7.2 GlobalData Consulting 36
7.3 Contact Us 36
7.4 Disclaimer 37

1.1 List of Tables
Table 1: Clinical Chemistry Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 9
Table 2: Clinical Chemistry Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 11
Table 3: Clinical Chemistry Analyzers Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 13
Table 4: Therapeutic Drug Monitoring Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 15
Table 5: Urine Analysis Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 17
Table 6: Clinical Chemistry Analyzers Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 19
Table 7: Therapeutic Drug Monitoring Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 21
Table 8: Urine Analysis Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 23
Table 9: Clinical Chemistry Market, Australia, Distribution Share by Revenue ($m), USD Constant, 2013-2014 24
Table 10: Clinical Chemistry Market, Australia, Company Share by Revenue ($m), USD Constant, 2014 26
Table 11: Clinical Chemistry Market Pipeline Products 30
Table 12: NoemaLife Enters into Distribution Agreement with Horiba Medical 33

1.2 List of Figures
Figure 1: Clinical Chemistry Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 8
Figure 2: Clinical Chemistry Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 10
Figure 3: Clinical Chemistry Analyzers Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 12
Figure 4: Therapeutic Drug Monitoring Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 14
Figure 5: Urine Analysis Market, Australia, Revenue ($m), USD Constant, Historic, 2007-2014 16
Figure 6: Clinical Chemistry Analyzers Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 18
Figure 7: Therapeutic Drug Monitoring Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 20
Figure 8: Urine Analysis Market, Australia, Revenue ($m), USD Constant, Forecast, 2014-2021 22
Figure 9: Clinical Chemistry Market, Australia, Company Share (%) 2014 25

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 Europe Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2017 Europe Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

  • $ 47500
  • Industry report
  • January 2017
  • by Venture Planning Group

This new report from VPGMarketResearch.com provides granular analysis of the Europe diagnostic testing market, including Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, ...

2017 Asia-Pacific Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2017 Asia-Pacific Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

  • $ 35000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new report from VPGMarketResearch.com provides granular analysis of the Asia-Pacific diagnostic testing market, including Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, ...

2017 Middle East Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2017 Middle East Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

  • $ 24500
  • Industry report
  • January 2017
  • by Venture Planning Group

This new report from VPGMarketResearch.com provides granular analysis of the Middle East diagnostic testing market, including Bahrain, Iran, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.